A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

• 

• 
  • The Journal
  • Editor-In-Chief
  • Editorial Calendar
  • Submissions
  • Advertising
  • Permissions & Reprints
  • Privacy Policy

• 
  • Subscribe
  • Renew
  • Prices
  • Free Sample

• 
  • View Shopping Cart
  • Back Issues
  • Articles
  • Library Archives
  • Compounding Theme Archives
  • Other Products

• 
  • Supplemental Content and Errata
  • Training and Education
  • IJPC-PCAB SOP Matrix
  • USP GAP Analysis
  • Compounders' Network List
  • Patient Information
  • Videos
  • Compounders' Resource Directory

• 

• 

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2015 - Volume 19, Number 1
View All Articles in Issue

Note:  Electronic version includes supplemental material.

Abstract:  The world of pharmaceuticals is changing rapidly as biotechnology continues to grow and nanotechnology appears on the horizon. Biotechnology is gaining in importance in extemporaneous pharmaceutical compounding, and nanotechnology and pharmacogenomics could drastically change the practice of pharmacy. This article discusses biotechnology and the factors to consider when compounding biotechnology drugs.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, biotechnology, cloning, recombinant DNA, recombinant proteins, transgenic organisms, route of administration, peptides, small molecules, excipients, drug carriers

Related Categories: EXCIPIENTS, HISTORY, STABILITIES, COMPATIBILITIES, TECHNOLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1	Allen Loyd V Jr	Jan/Feb 2015	38-40	Buy
Compounding with Biotechnology Products, Part 2: Product-specific Considerations	Allen Loyd V Jr	Nov/Dec 2022	446-466	Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh	Allen Loyd V Jr	Nov/Dec 2003	449-450	Buy
Compounding with Biotechnology Products, Part 1: General Considerations	Allen Loyd V Jr	Sep/Oct 2022	385-395	Buy
Basics of Sterile Compounding: Manipulating Peptides and Proteins	Akers Michael J	May/Jun 2017	223-228	Buy
Basics of Compounding: Basics of Compounding with Complex Organic Molecules	Allen Loyd V Jr	May/Jun 2011	234-238	Buy
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2	Allen Loyd V	Jul/Aug 2015	280-287	Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs	Allen Loyd V Jr	Sep/Oct 2017	356	Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Allen Loyd V Jr	Jul/Aug 2016	351	View Sample
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs	Allen Loyd V Jr	Nov/Dec 2015	487-488	Buy